Merck Gains Positive Opinion For Januvia In EU
This article was originally published in The Pink Sheet Daily
Executive Summary
Firm expects final EU clearance in early April.
You may also be interested in...
Merck’s Januvia Scores European Approval
Firm also awaiting a decision in the U.S. on sitagliptin/metformin combination Janumet, expected this week.
Merck’s Januvia Scores European Approval
Firm also awaiting a decision in the U.S. on sitagliptin/metformin combination Janumet, expected this week.
Galvus “Approvable” Letter Requests Additional Study In Renal Failure Patients
Analysts indicate approval of the type 2 diabetes therapy could be delayed for a year or more.